National and Kapodistrian University of Athens
Δημιουργία, in vitro πολλαπλασιασμός και διαφοροποίηση ανθρώπινων επαγόμενων πολυδύναμων βλαστοκυττάρων
Abstract
dc:descriptionThe innovation of reprogramming somatic cells to induced pluripotent stem cells (iPSCs) provides a possible new approach for patient-specific cell-based therapies and disease modeling. Since the pioneer work of Takahashi and Yamanaka in 2007, many methods have been reported on the generation of human iPSCs. In this study, we investigated the generation of iPSCs from bone marrow derived mesenchymal stromal cells (MSCs) isolated from a healthy donor and a patient who was diagnosed with β-thalassemia major using a transgene-free mRNA-based method. Bone marrow derived - MSCs from a healthy donor and a patient with β-thalassemia were transfected with synthetic modified mRNA encoding the transcription factors Oct4, Klf4, Sox2, Lin28, and c-Myc. The transfection of human skin fibroblasts was used as positive control. The iPSC colonies emerged were manually isolated and transferred to feeder-free cultures for proliferation. A number of molecular assays were performed to further assess whether iPSCs had been reprogrammed to pluripotency (flow cytometry, RT-PCR, gene expression microarrays). Their expression pattern was directly compared with that of a very well described embryonic stem cell line. The developmental potential of iPSCs was tested in vitro by the formation of embryoid bodies (EBs) and in vivo by teratoma assay, as well as by their ability to differentiate in vitro into hematopoietic stem cells. The genetic stability of iPSCs was evaluated with array comparative genomic hybridization (aCGH). Target cell types successfully generated iPSC colonies and three iPSC lines derived from each of them. The molecular analyses revealed that the iPSC clones closely recapitulated the molecular properties of human embryonic stem cells. Trilineage differentiation potential was confirmed by the generation of EBs in vitro and the formation of teratomas in vivo, which histologically revealed cell types of the three germ layers. The aCGH analyses showed copy number variations (CNVs) in 10th passage iPSCs included deletions approx. 3Mb. Differentiation cultures toward hematopoietic lineage led to the generation of CD34+ progenitors that were 8-10% of the produced cells and with dim co-expression of CD45. We report herein for the first time in Greece, the generation of human iPSC using a safe, transgene-free method that can be widely used for drug discovery, disease modeling and gene therapy applications.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Varela, Ioanna
- Βαρελά, Ιωάννα
Subjects
dc:subject × 6Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38471